Sichuan Hebang Biotechnology Corporation Limited (603077.SS) SHH

Currency In CNY

AD

Valuation

Market Cap18.04B
Enterprise Value20.05B
P/E Ratio-82.02
PEG Ratio0.1
Price/Sales Ratio2.85
Price/Book Ratio0.92
Enterprise/Revenue3.1
Enterprise/EBITDA29.41

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.03
Operating Margin-0.01
AD

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.01

Income Statement

Revenue7.18B
Revenue/Share0.76
Gross Profit671.57M
EBITDA506.89M
Net Income-536.41M
Diluted EPS-0.07

Balance Sheet

Total Cash7.24B
Total Cash/Share0.89
Total Debt8.82B
Total Debt/Equity0.46
Current Ratio4.92
Book Value Per Share2.38

Price History

52-Week Change-4.37
52-Week High3.54
52-Week Low2.07
Moving Average 50 Days2.35
Moving Average 200 Days2.53

Statistics

Average Volume182.73M
Shares Outstanding8B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.52
Last Split Factor11:5
Last Split DateJuly 05, 2017
AD